Bennett W M, McDonald W J, Kuehnel E, Hartnett M N, Porter G A
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):499-504.
To ascertain whether diuretics have an antihypertensive effect independent of natriuresis, 12 stable patients on maintenance hemodialysis underwent a crossover evaluation with hydrochlorothiazide, 50 mg daily, metolazone, 5 mg daily, or placebo in 4-wk treatment periods for 6 mo. Compliance was assured by pill counts and serum drug concentrations. All patients had daily urine less than 100 ml. Pre- and postdialysis blood pressure, body weight, plasma volume, and plasma renin activity were monitored. Over the 6-mo study period there were no statistically significant changes in any parameter related to diuretic therapy. It is concluded that a functioning kidney with the ability to respond to diuretics with a natriuresis is necessary for the antihypertensive action of diuretics. Direct vascular effects of diuretics to lower peripheral resistance could not be demonstrated in this unique patient population.
为确定利尿剂是否具有独立于利钠作用的降压效果,12名维持性血液透析稳定患者在为期6个月的时间里,接受了为期4周的交叉评估,分别服用每日50毫克氢氯噻嗪、每日5毫克美托拉宗或安慰剂。通过药丸计数和血清药物浓度确保患者依从性。所有患者每日尿量均少于100毫升。监测透析前和透析后的血压、体重、血浆容量和血浆肾素活性。在为期6个月的研究期间,与利尿剂治疗相关的任何参数均无统计学显著变化。得出的结论是,具有对利尿剂产生利钠反应能力的功能正常的肾脏,对于利尿剂的降压作用是必要的。在这一独特的患者群体中,未能证明利尿剂降低外周阻力的直接血管效应。